FFA
RDY icon

Frazier Financial Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Frazier Financial Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-180
Closed -$2.86K – 829
2024
Q3 		$2.86K Sell
180
-410
-69% -$6.6K ﹤0.01% 648
2024
Q2 		$8.99K Sell
590
-540
-48% -$7.74K 0.01% 466
2024
Q1 		$16.6K Buy
1,130
+995
+737% +$14.5K 0.01% 301
2023
Q4 		$1.88K Buy
+135
New +$1.8K ﹤0.01% 678

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Frazier Financial Advisors's RDY Position: Q4 2024 in Review

Frazier Financial Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2024, closing a stake of 180 shares — an estimated $2.86K sold.

Frazier Financial Advisors first reported a position in RDY in Q4 2023 and held it in 4 quarters. The position peaked at $16.6K in Q1 2024. 248 funds tracked by Wall St. Rank hold RDY as of Q4 2024.

  • Frazier Financial Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2024 after selling out during the quarter.
  • Frazier Financial Advisors sold 180 Dr. Reddy's Laboratories shares in Q4 2024, an estimated $2.86K.
  • Frazier Financial Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2023 and held it in 4 quarters.
  • Frazier Financial Advisors's Dr. Reddy's Laboratories position peaked at $16.6K in Q1 2024.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2024.

Based on Frazier Financial Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.